Literature DB >> 1857235

Assay and purification of naturally occurring inhibitor of angiogenesis.

P J Polverini, N P Bouck, F Rastinejad.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 1857235     DOI： 10.1016/0076-6879(91)98044-7

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  22 in total

1.  Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats.

Authors:  O V Volpert; W F Ward; M W Lingen; L Chesler; D B Solt; M D Johnson; A Molteni; P J Polverini; N P Bouck
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

2.  Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth.

Authors:  P Lin; P Polverini; M Dewhirst; S Shan; P S Rao; K Peters
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

Review 3.  A critical analysis of current in vitro and in vivo angiogenesis assays.

Authors:  Carolyn A Staton; Malcolm W R Reed; Nicola J Brown
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

4.  Assays for the antiangiogenic and neurotrophic serpin pigment epithelium-derived factor.

Authors:  Preeti Subramanian; Susan E Crawford; S Patricia Becerra
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

5.  Low content of the natural ocular anti-angiogenic agent pigment epithelium-derived factor (PEDF) in aqueous humor predicts progression of diabetic retinopathy.

Authors:  B O Boehm; G Lang; O Volpert; P M Jehle; A Kurkhaus; S Rosinger; G K Lang; N Bouck
Journal:  Diabetologia       Date:  2003-03-01       Impact factor: 10.122

6.  A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1.

Authors:  O V Volpert; J Lawler; N P Bouck
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

7.  CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth.

Authors:  A M Babic; M L Kireeva; T V Kolesnikova; L F Lau
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

8.  Local delivery of a synthetic endostatin fragment for the treatment of experimental gliomas.

Authors:  Gustavo Pradilla; Federico G Legnani; Giovanna Petrangolini; Pierangelo Francescato; Francesco Chillemi; Betty M Tyler; Sergio M Gaini; Henry Brem; Alessandro Olivi; Francesco DiMeco
Journal:  Neurosurgery       Date:  2005-11       Impact factor: 4.654

9.  Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo.

Authors:  A M Babic; C C Chen; L F Lau
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

10.  Androgen receptor targets NFkappaB and TSP1 to suppress prostate tumor growth in vivo.

Authors:  Thomas Nelius; Stephanie Filleur; Alexander Yemelyanov; Irina Budunova; E Shroff; Yelena Mirochnik; Arin Aurora; Dorina Veliceasa; Wuhan Xiao; Zhou Wang; Olga V Volpert
Journal:  Int J Cancer       Date:  2007-09-01       Impact factor: 7.396
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.